Cargando…

Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer

Homologous recombination (HR) is a DNA repair pathway that is deficient in 50% of high-grade serous ovarian carcinomas (HGSOC). Deficient HR (DHR) constitutes a therapeutic opportunity for these patients, thanks to poly (ADP-ribose) polymerases (PARP) inhibitors (PARPi; olaparib, niraparib, and ruca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romeo, Margarita, Pardo, Juan Carlos, Martínez-Cardús, Anna, Martínez-Balibrea, Eva, Quiroga, Vanesa, Martínez-Román, Sergio, Solé, Francesc, Margelí, Mireia, Mesía, Ricard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214122/ https://www.ncbi.nlm.nih.gov/pubmed/30347758 http://dx.doi.org/10.3390/ijms19103249

Ejemplares similares

Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data
por: Bernat-Peguera, Adrià, et al.
Publicado: (2022)

Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types
por: Felip, Eudald, et al.
Publicado: (2022)

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis
por: Gutiérrez-Chamorro, Lucía, et al.
Publicado: (2023)

Targeting homologous recombination addicted tumors: challenges and opportunities
por: Golan, Talia, et al.
Publicado: (2020)

Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients
por: Hardy-Werbin, Max, et al.
Publicado: (2019)

Nanoparticle albumin-bound paclitaxel in a patient with locally advanced breast cancer and taxane-induced skin toxicity: a case report
por: Cirauqui, Beatriz Cirauqui, et al.
Publicado: (2014)

Conventional and digital Ki67 evaluation and their correlation with molecular prognosis and morphological parameters in luminal breast cancer
por: Pons, Laura, et al.
Publicado: (2022)

Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma
por: Planas‐Paz, Lara, et al.
Publicado: (2023)

Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer
por: Pons, Laura, et al.
Publicado: (2023)

Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy
por: Castellví, Marc, et al.
Publicado: (2020)

The Knowns Unknowns: Exploring the Homologous Recombination Repair Pathway in Toxoplasma gondii
por: Fenoy, Ignacio M., et al.
Publicado: (2016)

PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines
por: Ginés, Alba, et al.
Publicado: (2015)

Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance
por: Kumar, Subodh, et al.
Publicado: (2018)

Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713
por: Castellví, Marc, et al.
Publicado: (2020)

Real‐world treatment outcomes of medicines used in special situations (off‐label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution
por: Fontanals, Sandra, et al.
Publicado: (2023)

Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?
por: España Fernandez, Sofia, et al.
Publicado: (2023)

The clinical challenges of homologous recombination proficiency in ovarian cancer: from intrinsic resistance to new treatment opportunities
por: Zielli, Teresa, et al.
Publicado: (2023)

Elp1 facilitates RAD51-mediated homologous recombination repair via translational regulation
por: Chen, Wei-Ting, et al.
Publicado: (2021)

The courtship choreography of homologous chromosomes: timing and mechanisms of DSB-independent pairing
por: Solé, Mireia, et al.
Publicado: (2023)

Homologous recombination-mediated irreversible genome damage underlies telomere-induced senescence
por: Ghadaouia, Sabrina, et al.
Publicado: (2021)

Homologous recombination and its regulation
por: Krejci, Lumir, et al.
Publicado: (2012)

BRCA2 and homologous recombination
por: Orelli, Brian J, et al.
Publicado: (2001)

Homologous Recombination: To Fork and Beyond
por: Prado, Félix
Publicado: (2018)

The Regulation of Homologous Recombination by Helicases
por: Huselid, Eric, et al.
Publicado: (2020)

Structural basis of homologous recombination
por: Sun, Yueru, et al.
Publicado: (2019)

[Translated article] Oxygen therapy. Considerations regarding its use in acute ill patients()
por: Valencia Gallardo, José Manuel, et al.
Publicado: (2022)

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
por: Martinez-Balibrea, E, et al.
Publicado: (2010)

Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead
por: Tsang, Erica S, et al.
Publicado: (2022)

Hotspots of homologous recombination in the human genome: not all homologous sequences are equal
por: Lupski, James R
Publicado: (2004)

Impact of homologous and non-homologous recombination in the genomic evolution of Escherichia coli
por: Didelot, Xavier, et al.
Publicado: (2012)

Homologous Recombination and Its Role in Carcinogenesis
por: Bishop, Alexander J. R., et al.
Publicado: (2002)

Investigations of Homologous Recombination Pathways and Their Regulation
por: Daley, James M., et al.
Publicado: (2013)

Creating Hybrid Genes by Homologous Recombination
por: Wang, Peter L.
Publicado: (2000)

Initiation of homologous recombination at DNA nicks
por: Maizels, Nancy, et al.
Publicado: (2018)

The many facets of homologous recombination at telomeres
por: Claussin, Clémence, et al.
Publicado: (2015)

Homologous Recombination Deficiencies and Hereditary Tumors
por: Yamamoto, Hideki, et al.
Publicado: (2021)

Biomarkers for Homologous Recombination Deficiency in Cancer
por: Wagener-Ryczek, Svenja, et al.
Publicado: (2021)

Chromosome architecture and homologous recombination in meiosis
por: Ito, Masaru, et al.
Publicado: (2023)

SERBP1 affects homologous recombination-mediated DNA repair by regulation of CtIP translation during S phase
por: Ahn, Jang-Won, et al.
Publicado: (2015)

Identification of translationally controlled tumor protein in promotion of DNA homologous recombination repair in cancer cells by affinity proteomics
por: Li, Y, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7otlfvlr27hdvhjktnfh2r2pdg